Insurance
Oscar Health Executive Compensation (FY25)
OSCR · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ Mark Bertolini | Latest say-on-pay support = June 4, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
The paid brief on Oscar Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Data as of November 5, 2026Latest filing (8-K): June 9, 2026
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
238 figures on this page: 234 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
More on Oscar Health
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Mark Bertolini: $915,000 → $1,149,308 (25.6% higher)
CEO pay ratio: 8:1 → 10.4:1 (30.0% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Oscar Health's chief executive and what were they paid?
Mark Bertolini was paid $1,149,308 in total compensation as Chief Executive Officer for fiscal 2025. Compared with the $915,000 reported for fiscal 2024, Bertolini's total was 25.6% higher.
What was Oscar Health's say-on-pay result?
The say-on-pay proposal drew 98.9% of votes cast for or against in favor at the meeting held June 4, 2026 for fiscal 2025.
Which companies are in Oscar Health's peer group?
Companies named in the disclosed peer group include Concentrix, DaVita, GoodRx, HealthEquity and Labcorp. Companies named in the Compensation Peer Group include Concentrix, DaVita, GoodRx, HealthEquity and Labcorp. The 2025 rTSR Peer Group includes Centene Corporation, Cigna Group, CVS Health Corporation and Humana Inc.
What is Oscar Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 10.4:1, against median employee compensation of $110,162.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Siddhartha Sankaran Interim Chief Financial Officer | — | — | ◇ | — | — | — | — | ◇ |
Ranmali Bopitiya Chief Legal Officer | ◇ | ◇ | — | — | ◇ | — | ◇ | ◇ |
Dennis Weaver Former Chief Clinical Officer Departed during or after this year | ◇ | — | — | — | ◇ | — | ◇ | — not reconciled |
Alessandrea Quane Chief Insurance Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
R. Scott Blackley Chief Transformation Officer and Former Chief Financial Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
Mario Schlosser Co-Founder, President of Technology & Chief Technology Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Mark Bertolini Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
Scott Blackley Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Mario Schlosser Co-Founder, President of Technology & Chief Technology Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Mario Schlosser Co-Founder, President of Technology & Chief Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
R. Scott Blackley Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Alessandrea Quane Chief Insurance Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ranmali Bopitiya Chief Legal Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Mark Bertolini Chief Executive Officer | ◇ | — | — | — | ◇ | — | — | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Janet Liang President of Oscar Insurance | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Mario Schlosser Co-Founder, President of Technology & Chief Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Adam McAnaney Chief Legal Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Scott Blackley Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Mark Bertolini Chief Executive Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Adam McAnaney | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Adam McAnaney | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Adam McAnaney | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Adam McAnaney | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Janet Liang | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Janet Liang | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Janet Liang | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Janet Liang | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Mario Schlosser | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Mario Schlosser | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| R. Scott Blackley | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| R. Scott Blackley | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Scott Blackley | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Scott Blackley | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Mark Bertolini | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Scott Blackley | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | March 29, 2033 | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Adam McAnaney | Option | ◇ | — | ◇ | February 24, 2035 |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Mario Schlosser | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Janet Liang | Option | ◇ | — | ◇ | February 24, 2035 |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Mario Schlosser
Co-Founder, President of Technology & Chief Technology Officer · Terms as described in the company’s compensation discussion
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Jeffery H. Boyd Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Laura Lang | ◇ | ◇ | — | — | — | — | ◇ |
Vanessa A. Wittman | ◇ | ◇ | — | — | — | — | ◇ |
David Plouffe | ◇ | ◇ | — | — | — | — | ◇ |
William Gassen III | ◇ | ◇ | — | — | — | — | ◇ |
Siddhartha Sankaran | ◇ | ◇ | — | — | — | — | ◇ |
Elbert O. Robinson Jr | ◇ | — | — | — | — | — | ◇ |
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Concentrix CNXC
- DaVita DVA
- GoodRx GDRX
- HealthEquity HQY
- Labcorp LH
Compensation Peer Group
- Concentrix CNXC
- DaVita DVA
- GoodRx GDRX
- HealthEquity HQY
- Labcorp LH
2025 rTSR Peer Group
- Centene Corporation CNC
- Cigna Group CI
- CVS Health Corporation CVS
- Humana Inc. HUM
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 4, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 4, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 6, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 8, 2023 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Oscar Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Oscar Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
238 figures on this page: 234 cited to the filing that reported them, 4 calculated from figures it prints.
234 cited to the filing
4 calculated from the filing
Documents cited
- 0001568651-26-000059Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-26-016119Director Compensation · Executive Compensation Tables · Grants of Plan-Based Awards
- 000114036126016119CEO Pay Ratio
- 0001193125-25-137039Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-25-015601Compensation Discussion and Analysis · Summary Compensation Table
- 0001193125-24-159132Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-23-166046Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-23-120140Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Oscar Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/OSCR (accessed 2026).
Short form: data: Velarion
The paid brief for Oscar Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Oscar Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Insurance rankings
Peers Oscar Health discloses
The companies named in OSCR's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}